RICERCA
AUTORI
RIVISTE
Sfoglia per RIVISTA
TRANSLATIONAL LUNG CANCER RESEARCH
Collezione AO Ordine Mauriziano
Items : 7
First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jun;10(6):2917-2936. doi: 10.21037/tlcr-21-15.
2021
AO Ordine Mauriziano
Facchinetti F; Di Maio M; Perrone F; Tiseo M;
Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jun;10(6):2890-2916. doi: 10.21037/tlcr-20-941.
2021
AO Ordine Mauriziano
Guaitoli G; Tiseo M; Di Maio M; Friboulet L; Facchinetti F;
A narrative review of primary research endpoints of neoadjuvant therapy for lung cancer: past, present and future. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jul;10(7):3264-3275. doi: 10.21037/tlcr-21-259.
2021
AO Ordine Mauriziano
Ren S; Xu A; Lin Y; Camidge DR; Di Maio M; Califano R; Hida T; Rossi A; Guibert N; Zhu C; Shen J;
Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2696-2715. doi: 10.21037/tlcr-2020-63.
2020
AO Ordine Mauriziano
Liang W; Cai K; Chen C; Chen H; Chen Q; Fu J; Hu J; Jiang T; Jiao W; Li S; Liu C; Liu D; Liu W; Liu Y; Ma H; Pan X; Qiao G; Tian H; Wei L; Zhang Y; Zhao S; Zhao X; Zhou C; Zhu Y; Zhong R; Li F; Rosell R; Provencio M; Massarelli E; et alii...
The KEY for chemo-immunotherapy combination: taking NOTEs from squamous cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Apr;9(2):410-413. doi: 10.21037/tlcr.2020.02.02.
2020
AO Ordine Mauriziano
Di Maio M; De Luca E; Reale ML;
Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer? in Translational lung cancer research / Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S294-S296. doi: 10.21037/tlcr.2018.07.12.
2018
AO Ordine Mauriziano
Metro G; Di Maio M;
Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer? in Translational lung cancer research / Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S290-S293. doi: 10.21037/tlcr.2018.07.11.
2018
AO Ordine Mauriziano
Metro G; Di Maio M;